[Erectile dysfunction after surgery for rectosigmoid tumors--diagnosis and therapy]

Area of Science:

• Oncology
• Urology
• Sexual Medicine

Context:

• Radical rectosigmoid tumor resections can significantly impact male sexual function.
• Erectile dysfunction (ED) is a common, yet often underdiagnosed and undertreated, complication following these procedures.

Purpose:

• To evaluate the diagnostic and therapeutic strategies for managing ED after rectosigmoid cancer surgery.
• To assess the efficacy of current ED treatments in this specific patient population.

Summary:

• A study of 167 men undergoing rectosigmoid surgery found ED developed in 68.6% of those with pre-existing sexual activity.
• Libido and ejaculation were also frequently impaired post-surgery.
• Only 40% of men with ED received examination or treatment, with oral sildenafil showing limited efficacy and intracavernous injections being effective but underutilized.

Impact:

• Highlights the significant prevalence of ED after rectosigmoid cancer surgery.
• Underscores the need for improved screening, diagnosis, and treatment protocols for post-surgical ED.
• Suggests a potential role for intracavernous injections despite patient reluctance.